| RLF Stock | | | CHF 4.01 0.14 3.37% |
Relief Therapeutics Holding
fundamentals help investors to digest information that contributes to Relief Therapeutics' financial success or failures. It also enables traders to predict the movement of Relief Stock. The
fundamental analysis module provides a way to measure
Relief Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various
microeconomic indicators and financial ratios related to Relief Therapeutics stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to
Equity Screeners to view more equity screening tools.
Relief Therapeutics Holding Company Retained Earnings Analysis
Relief Therapeutics' Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
Based on the latest financial disclosure, Relief Therapeutics Holding has a Retained Earnings of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the
Biotechnology industry. The retained earnings for all Switzerland stocks is 100.0% higher than that of the company.
| | Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
Relief Fundamentals
About Relief Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Relief Therapeutics Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Relief Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at
the intrinsic value of Relief Therapeutics Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing
financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Relief Stock Analysis
When running Relief Therapeutics' price analysis, check to
measure Relief Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relief Therapeutics is operating at the current time. Most of Relief Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Relief Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relief Therapeutics' price. Additionally, you may evaluate how the addition of Relief Therapeutics to your portfolios can decrease your overall portfolio volatility.